Frequency of Metabolic Syndrome in Down Syndrome Patients
NCT ID: NCT00864461
Last Updated: 2017-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2009-09-01
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population
NCT01176630
Retrospective Analysis for Patients With Metabolic Syndrome
NCT06182618
Effect of a Low Glycemic Index on Metabolic Syndrome
NCT02356952
Mechanisms of Exercise Resistance in Metabolic Disease
NCT03945435
The Reversal Intervention for Metabolic Syndrome Study
NCT01043770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Patients with clinical and cytogenetics diagnosis of Down syndrome, between 7 - 24 years old.
No interventions assigned to this group
Control
Siblings of the same gender of the case, between 7-24 years old.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of gastroenterologic anomalies requiring bowel resection and/or ongoing medical intervention
* History of leukemia or other cancer
* History of hypothyroidism requiring thyroid hormone replacement
7 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Guanajuato
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ALEJANDRO ERNESTO MACIAS HERNANDEZ
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Medicine, University of Guanajuato
León, Guanajuato, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
249-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.